Holen Sie sich die Stockscreener-App
210.20
1.81%
-4.03
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt MS?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$214.23
Offen:
$214.29
24-Stunden-Volumen:
1.71M
Relative Volume:
0.30
Marktkapitalisierung:
$330.29B
Einnahmen:
$128.77B
Nettoeinkommen (Verlust:
$20.37B
KGV:
16.99
EPS:
12.3718
Netto-Cashflow:
$39.02B
1W Leistung:
-3.67%
1M Leistung:
-0.28%
6M Leistung:
+19.92%
1J Leistung:
+45.96%
1-Tages-Spanne:
$209.87
$215.06
1-Wochen-Bereich:
$209.87
$220.53
52-Wochen-Spanne:
$142.90
$232.25
Morgan Stanley Stock (MS) Company Profile
Firmenname
Morgan Stanley
Sektor
Branche
Telefon
212-761-4000
Adresse
1585 BROADWAY, NEW YORK, NY
Compare MS vs GS, SCHW, HOOD, IBKR
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MS
Morgan Stanley
|
210.30 | 336.46B | 128.77B | 20.37B | 39.02B | 12.37 |
GS
Goldman Sachs Group Inc
|
1,007.54 | 297.48B | 128.57B | 20.97B | 112.72B | 64.79 |
SCHW
Charles Schwab Corp
|
111.06 | 191.75B | 28.33B | 9.42B | 9.76B | 5.0426 |
HOOD
Robinhood Markets Inc
|
94.16 | 86.11B | 4.65B | 1.89B | -2.09B | 2.0676 |
IBKR
Interactive Brokers Group Inc
|
90.75 | 41.02B | 10.76B | 4.56B | 35.82B | 2.326 |
Morgan Stanley Stock (MS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-06-30 | Herabstufung | Oppenheimer | Perform → Underperform |
| 2026-04-27 | Hochstufung | Erste Group | Hold → Buy |
| 2026-04-07 | Hochstufung | UBS | Neutral → Buy |
| 2026-03-05 | Herabstufung | Erste Group | Buy → Hold |
| 2025-11-24 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2025-10-03 | Eingeleitet | BMO Capital Markets | Outperform |
| 2025-07-09 | Hochstufung | Keefe Bruyette | Mkt Perform → Outperform |
| 2024-11-26 | Herabstufung | HSBC Securities | Buy → Hold |
| 2024-11-15 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2024-10-04 | Hochstufung | HSBC Securities | Hold → Buy |
| 2024-09-11 | Herabstufung | Goldman | Buy → Neutral |
| 2024-08-02 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2024-07-17 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2024-01-17 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2024-01-17 | Herabstufung | Keefe Bruyette | Outperform → Mkt Perform |
| 2024-01-09 | Herabstufung | HSBC Securities | Buy → Hold |
| 2023-11-28 | Herabstufung | Societe Generale | Buy → Hold |
| 2023-11-20 | Herabstufung | Exane BNP Paribas | Outperform → Neutral |
| 2023-10-23 | Herabstufung | Odeon | Buy → Hold |
| 2023-10-20 | Hochstufung | Wolfe Research | Underperform → Peer Perform |
| 2023-10-11 | Herabstufung | UBS | Buy → Neutral |
| 2023-09-07 | Eingeleitet | HSBC Securities | Buy |
| 2023-07-12 | Hochstufung | Odeon | Hold → Buy |
| 2023-01-18 | Herabstufung | Citigroup | Buy → Neutral |
| 2023-01-10 | Hochstufung | Odeon | Sell → Hold |
| 2023-01-04 | Herabstufung | Wolfe Research | Outperform → Underperform |
| 2022-10-05 | Herabstufung | Atlantic Equities | Overweight → Neutral |
| 2022-09-06 | Herabstufung | Odeon | Hold → Sell |
| 2022-05-03 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2022-01-28 | Herabstufung | Odeon | Buy → Hold |
| 2021-12-03 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-10-15 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2021-10-04 | Bestätigt | Jefferies | Buy |
| 2021-09-29 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2021-09-28 | Herabstufung | Berenberg | Buy → Hold |
| 2021-08-13 | Herabstufung | Seaport Global Securities | Buy → Neutral |
| 2021-07-07 | Fortgesetzt | Keefe Bruyette | Outperform |
| 2021-06-09 | Eingeleitet | Jefferies | Buy |
| 2021-04-21 | Hochstufung | Berenberg | Hold → Buy |
| 2021-03-02 | Hochstufung | Daiwa Securities | Neutral → Outperform |
| 2021-01-06 | Eingeleitet | Daiwa Securities | Neutral |
| 2021-01-04 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2020-11-10 | Herabstufung | Citigroup | Buy → Neutral |
| 2020-10-13 | Fortgesetzt | JP Morgan | Overweight |
| 2020-07-08 | Eingeleitet | Seaport Global Securities | Buy |
| 2020-06-24 | Hochstufung | DA Davidson | Neutral → Buy |
| 2020-06-23 | Bestätigt | UBS | Buy |
| 2020-05-21 | Hochstufung | Odeon | Hold → Buy |
| 2020-04-14 | Hochstufung | Societe Generale | Sell → Buy |
| 2020-03-13 | Hochstufung | Goldman | Neutral → Buy |
| 2020-03-04 | Hochstufung | Citigroup | Neutral → Buy |
| 2020-02-21 | Herabstufung | DA Davidson | Buy → Neutral |
| 2020-02-20 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2020-01-21 | Herabstufung | Citigroup | Buy → Neutral |
| 2020-01-17 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2020-01-13 | Herabstufung | JMP Securities | Mkt Outperform → Mkt Perform |
| 2020-01-09 | Eingeleitet | DA Davidson | Buy |
| 2020-01-06 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2019-10-29 | Herabstufung | Odeon | Buy → Hold |
| 2019-10-10 | Hochstufung | Sandler O'Neill | Hold → Buy |
| 2019-07-12 | Hochstufung | Citigroup | Neutral → Buy |
| 2019-04-18 | Herabstufung | Citigroup | Buy → Neutral |
Alle ansehen
Morgan Stanley Aktie (MS) Neueste Nachrichten
Industrial real estate is a side-door way into AI, says Morgan Stanley’s Lauren Hochfelder - CNBC
BILL's FY27 Outlook Shows Slower Core Growth Despite Q4 Profit Gain, Morgan Stanley Says - marketscreener.com
REGJTC PLC Morgan StanleyHolding(s) in Company - TradingView
A Little-Known Firm Owns Nearly 3,000 Times More of This XRP ETF Than Morgan Stanley - Yahoo Finance
Estee Lauder's Turnaround Progressing on Organic Sales Growth Momentum, Morgan Stanley Says - marketscreener.com
Morgan Stanley Said to Hire Barclays Tech Dealmaker Tim Luke - Bloomberg.com
Morgan Stanley sees modest downside risks to US aluminum premium By Investing.com - Investing.com Nigeria
Merck upgraded at Morgan Stanley after cancer trial win; RBC downgrades - Seeking Alpha
Morgan Stanley Reverses Its Ford Target Raise, Returning to $14 - eletric-vehicles.com
Morgan Stanley Says AI Data Centers Face a 38-Gigawatt Power Gap. These Industrial Stocks Fill It. - The Motley Fool
Alignment Healthcare to Present in Baird 2026 Global Healthcare Conference and Attend Morgan Stanley 24th Annual Global Healthcare Conference - The Manila Times
Morgan Stanley Forecasts Strong Price Appreciation for Moderna (NASDAQ:MRNA) Stock - MarketBeat
Morgan Stanley Says AI Data Centers Face a 38-Gigawatt Power Gap. These Industrial Stocks Fill It. - The Motley Fool
Merck is a buy as strong cancer drug pipeline offsets Keytruda patent expiration, Morgan Stanley says - CNBC
Morgan Stanley raises the price target for Novonesis to 535 Danish kroner (520), reiterates overweightBN - marketscreener.com
LILA Downgraded by Morgan Stanley -- Rating Changed to Underweig - GuruFocus
Morgan Stanley Maintains SpaceX(SPCX.US) With Buy Rating, Maintains Target Price $300 - Moomoo
Morgan Stanley is out with its gold price outlook for 2027 - Investing.com
PFC-REC merger may bring limited cost savings; some revenue benefits possible: Morgan Stanley - BusinessLine
MRK Upgraded by Morgan Stanley -- Price Target Raised to $179 - GuruFocus
PFC, REC shares decline up to 3% after Morgan Stanley cuts growth estimates - TradingView
Tim Luke Joins Morgan Stanley to Boost Tech Banking Amid Semicon - GuruFocus
Morgan Stanley Adjusts Price Target on BILL Holdings to $60 From $55, Maintains Equalweight Rating - marketscreener.com
Morgan Stanley Adjusts Price Target on SailPoint to $22 From $18, Maintains Overweight Rating - marketscreener.com
Morgan Stanley Adjusts PT on ProFrac Holding to $4.50 From $5, Keeps Underweight Rating - marketscreener.com
Morgan Stanley Adjusts Price Target on Liberty Energy to $30 From $32, Keeps Overweight Rating - marketscreener.com
Morgan Stanley Adjusts Price Target on Okta to $180 From $115, Maintains Overweight Rating - marketscreener.com
Morgan Stanley Adjusts PT on Patterson-UTI Energy to $12 From $11, Keeps Equalweight Rating - marketscreener.com
Morgan Stanley Adjusts Price Target on Tenaris to $60 From $65, Keeps Equalweight Rating - marketscreener.com
Morgan Stanley Upgrades Merck & Co. to Overweight From Equalweight, Adjusts PT to $179 From $116 - marketscreener.com
Morgan Stanley Downgrades Baidu as Ad Revenue Falls for 8th Straight Quarter and ERNIE Lags - Tech Times
Morgan Stanley poaches financials analyst from Bank of America - AFR
Dan Simkowitz to Speak at the Barclays Global Financial Services Conference - Morgan Stanley
Keurig Dr Pepper stock rating resumed at Overweight by Morgan Stanley - Investing.com
Morgan Stanley Resumes Keurig Dr Pepper (KDP) at Overweight - StreetInsider
PFC, REC Shares Fall As Morgan Stanley Downgrades Both Stocks — Check Target Price, Potential Upside - NDTV Profit
BIDU Rebounds After Q2 Selloff: Morgan Stanley Downgrades Stock, Sees More Earnings Pressure From AI Spending - TradingView
Morgan Stanley rates BWP as Equal-weight - marketscreener.com
Morgan Stanley rates TLC as Equal-weight - marketscreener.com
Scotiabank Hires Morgan Stanley's Richard Tory for Mining - Briefs Finance
Veteran Barclays Semiconductor Banker Tim Luke to Join Morgan Stanley - The Information
Morgan Stanley is said to hire Barclays tech dealmaker Tim LukeBloomberg News - TradingView
Morgan Stanley Expects Chevron (CVX) to Hit a New High. Can the Oil Giant Keep Rallying? - Yahoo Finance
Forbes Best-In-State Next-Gen Wealth Advisors 2026 List - Forbes
Adtran Holdings, Inc.: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution - TradingView
EU Commission clears acquisition of Nicollin, SMN, NHE, Nicollin Eau and MP3D Groupe by Morgan Stanley Infrastructure – INSIGHT EU MONITORING - INSIGHT EU MONITORING
A Bullish Signal Could Point to Gains Ahead for These Big Tech Stocks - Investopedia
Morgan Stanley raises Moderna stock price target to $89 on platform strength - Investing.com Canada
Morgan Stanley just laid out eBay's four possible paths forward - Yahoo Finance
Morgan Stanley upgrades Merck stock rating on drug pipeline strength - Investing.com
UiPath (NYSE: PATH) investor plans multimillion-dollar stock sale - Stock Titan
Finanzdaten der Morgan Stanley-Aktie (MS)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.47%
0.24%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):